Home / Stocks / VANTABIO
Back to all stocks
BSE · VANTABIO

Vanta Bioscience Limited (VANTABIO) Share Price

Sector: Healthcare · ISIN: INE695X01011

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,412
of 5,047 stocks
▼ 1371W▼ 761M
Peak #4,244 · 02 Oct 2026

A microcap name in Healthcare, Vanta Bioscience Limited carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 73%. Ownership as of Mar 2026.

Market Cap
13.16 Cr
P/E Ratio
123.33
P/B Ratio
0.62
ROE
0.51%
ROCE
1.46%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

Quarterly financials for this stock haven't been ingested yet — check back soon.

Shareholding pattern

Promoter
72.81%
Public
27.19%

PUBLIC BREAKDOWN

Individuals
24.58%

As of 31 Mar 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs